81 research outputs found

    Left Out Of The Game: Fast-Track, Non-Tariff Barriers, And The Erosion Of Federalism

    Get PDF
    On January 27, 1998, an embattled President Clinton stood before the nation promoting a litany of government initiatives in his State of the Union Address

    The Duty of Reasonable Care under the Customs Moderization Act of 1993

    Get PDF

    Ultralow noise performance of an 8.4-GHz maser-feedhorn system

    Get PDF
    A total system noise temperature of 6.6 K was demonstrated with an 8.4-GHz traveling wave maser and feedhorn operating in a cryogenic environment. Both the maser and feedhorn were inserted in the helium cryostat, with the maser operating in the 1.6-K liquid bath and the feedhorn cooled in the helium gas, with a temperature gradient along the horn ranging from the liquid bath temperature at its lower end to room temperature at its top. The ruby maser exhibited 43 dB of gain with a bandwidth of 76 MHz(-3 dB) centered at 8400 MHz. Discussions of the maser, cooled feedhorn, and cryostat designs are presented along with a discussion of the noise temperature measurements

    Extension of effort for lunar flight handbook detailed technical report

    Get PDF
    Lunar flight handbook - orbital departure windows, libration points, and lunar flight orbit estimation, theory, and operation

    Combination Treatment of Withalongolide a Triacetate with Cisplatin Induces Apoptosis by Targeting Translational Initiation, Migration, and Epithelial to Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma

    Get PDF
    Treatment regimens for head and neck squamous cell carcinoma (HNSCC) typically include cisplatin and radiotherapy and are limited by toxicities. We have identified naturally derived withalongolide A triacetate (WGA-TA) from Physalis longifolia as a lead compound for targeting HNSCC. We hypothesized that combining WGA-TA with cisplatin may allow for lower, less toxic cisplatin doses. HNSCC cell lines were treated with WGA-TA and cisplatin. After treatment with the drugs, the cell viability was determined by MTS assay. The combination index was calculated using CompuSyn. The expression of proteins involved in the targeting of translational initiation complex, epithelial to mesenchymal transition (EMT), and apoptosis were measured by western blot. Invasion and migration were measured using the Boyden-chamber assay. Treatment of MDA-1986 and UMSCC-22B cell lines with either WGA-TA or cisplatin alone for 72 h resulted in a dose dependent decrease in cell viability. Cisplatin in combination with WGA-TA resulted in significant synergistic cell death starting from 1.25 ÎĽM cisplatin. Combination treatment with WGA-TA resulted in lower cisplatin dosing while maintaining the downregulation of translational initiation complex proteins, the induction of apoptosis, and the blockade of migration, invasion, and EMT transition. These results suggest that combining a low concentration of cisplatin with WGA-TA may provide a safer, more effective therapeutic option for HNSCC that warrants translational validation

    Cranial nerve outcomes in regionally recurrent head & neck melanoma after sentinel lymph node biopsy

    Full text link
    Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/156007/1/lary28243.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/156007/2/lary28243_am.pd

    Resilience for Collaborative Applications on Clouds

    Get PDF
    International audienceBecause e-Science applications are data intensive and require long execution runs, it is important that they feature fault-tolerance mechanisms. Cloud and grid computing infrastructures often support system and network fault-tolerance. They repair and prevent communication and software errors. They allow also checkpointing of applications, duplication of jobs and data to prevent catastrophic hardware failures. However, only preliminary work has been done so far on application resilience, i.e., the ability to resume normal execution following application errors and abnormal executions. This paper is an overview of open issues and solutions for such errors detection and management. It also overviews the implementation of a workflow management system to design, deploy, execute, monitor, restart and resume distributed HPC applications on cloud infrastructures in cases of failures

    Automated High-Content Live Animal Drug Screening Using C. elegans Expressing the Aggregation Prone Serpin α1-antitrypsin Z

    Get PDF
    The development of preclinical models amenable to live animal bioactive compound screening is an attractive approach to discovering effective pharmacological therapies for disorders caused by misfolded and aggregation-prone proteins. In general, however, live animal drug screening is labor and resource intensive, and has been hampered by the lack of robust assay designs and high throughput work-flows. Based on their small size, tissue transparency and ease of cultivation, the use of C. elegans should obviate many of the technical impediments associated with live animal drug screening. Moreover, their genetic tractability and accomplished record for providing insights into the molecular and cellular basis of human disease, should make C. elegans an ideal model system for in vivo drug discovery campaigns. The goal of this study was to determine whether C. elegans could be adapted to high-throughput and high-content drug screening strategies analogous to those developed for cell-based systems. Using transgenic animals expressing fluorescently-tagged proteins, we first developed a high-quality, high-throughput work-flow utilizing an automated fluorescence microscopy platform with integrated image acquisition and data analysis modules to qualitatively assess different biological processes including, growth, tissue development, cell viability and autophagy. We next adapted this technology to conduct a small molecule screen and identified compounds that altered the intracellular accumulation of the human aggregation prone mutant that causes liver disease in α1-antitrypsin deficiency. This study provides powerful validation for advancement in preclinical drug discovery campaigns by screening live C. elegans modeling α1-antitrypsin deficiency and other complex disease phenotypes on high-content imaging platforms
    • …
    corecore